LXRX — Lexicon Pharmaceuticals, Inc. | XLV Holdings | StockAdder

(LXRX)

Lexicon Pharmaceuticals, Inc.

Live chart and latest LXRX stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

LXRX News

LXRX SEC Filings - Lexicon Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms

Apr 11, 2026 Yahoo Finance

How The Lexicon Pharmaceuticals (LXRX) Story Is Shifting With Fine Tuned Targets And Trials

Feb 22, 2026 MSN

LXRX stock up as NVO initiates phase I study of partnered obesity drug

Apr 10, 2026 simplywall.st

Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) Shares Climb 28% But Its Business Is Yet to Catch Up

Jan 22, 2026 Seeking Alpha

Lexicon Pharma spikes after insider buy

Feb 19, 2026 Investing.com

Lexicon Pharmaceuticals stock tumbles on public offering pricing

Jan 30, 2026 marketscreener.com

Certain Stock Options of Lexicon Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 1-APR-2026.

Mar 31, 2026 Yahoo Finance

H.C. Wainwright Raises its Price Target on Lexicon Pharmaceuticals, Inc. (LXRX) to $6 from $4 and Maintains a Buy Rating

Mar 12, 2026 Stock Titan

A new obesity pill enters human testing, triggering $10M for Lexicon

Mar 23, 2026 simplywall.st

Lexicon Pharmaceuticals (NASDAQ:LXRX) delivers shareholders notable 99% return over 1 year, surging 17% in the last week alone

Jan 17, 2026 Yahoo Finance

How A Reset Price Target Is Reframing The Story For Lexicon Pharmaceuticals (LXRX)

Jan 27, 2026 Stock Titan

Drug developer Lexicon raises $94.6M to fund pipeline and operations

Jan 30, 2026 Yahoo Finance

Citi Raises Lexicon Pharmaceuticals (LXRX) Outlook on Strength of Novo Nordisk Partnership Milestones

Jan 30, 2026 Stock Titan

LXRX SEC Filings - Lexicon Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms

Apr 1, 2026 Stock Titan

Lexicon Pharma plans Miami fireside chat, 3 investor events in March